Joseph Loscalzo, Director at IONIS PHARMACEUTICALS INC (IONS), sold 16,000 shares at $75.10 ($1.2M) on 2025-10-31, disclosed to the SEC on 2025-11-03.
Scheduled sale ($1.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IONS | SELL | 2025-09-04 | $962K | — | Filing → |
| IONS | SELL | 2024-11-14 | $1.0M | — | Filing → |